Here are some stem cell weekend reads for your enjoyment along with various links and headlines.
Some science pubs that caught my eye:
- Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model
- High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain
- Identification for Differential Localization of Putative Corneal Epithelial Stem Cells in Mouse and Human
- Tracing the origins of relapse in acute myeloid leukaemia to stem cells
- Hypothalamic regulation of regionally distinct adult neural stem cells and neurogenesis
There’s been a burst of stem cell policy papers recently focused on stem cell clinics that directly market unproven offerings to patients. These papers highlight what a mess we are all in within the stem cell field with a stem cell clinic industry that has run wild.
- Marketing of unproven stem cell–based interventions: A call to action by Sipp, Rasko, Caulfield, and colleagues.
and a duo of important, recent papers by Leigh Turner:
- On Clinicaltrials.gov featured here in the WaPo
- And then one from a few weeks back on stem cell court cases
Various news headlines:
- Innate reaction of hematopoietic stem cells to severe infections
- ‘Nano-in-micro’ stem cell delivery could rescue blood flow after injury
- Baby Boomers turn to stem cells for help with painful joints
- Stem cell ads: Promise much, deliver little
And this important, but not exactly good news story from RetractionWatch about a stem cell scientist Susana Gonzalez facing retraction of papers and more.
Any more stem cell weekend reads you can suggest?